Aging promotes progression of iga nephropathy: A systematic review and meta-analysis

American Journal of Nephrology

Volumn 38, Issue 3, 2013, Pages 241-252

  Duan, Zhi Yu ^a   Cai, Guang Yan ^a   Chen, Yi Zhi ^a   Liang, Shuang ^a   Liu, Shu Wen ^a   Wu, Jie ^a   Qiu, Qiang ^a   Lin, Shu Peng ^a   Zhang, Xue Guang ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Aging; End stage renal disease; IgA nephropathy; Meta analysis

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; IMMUNOGLOBULIN A;

AGING; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL INDICATOR; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATURIA; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; QUALITY CONTROL; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SENESCENCE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; AGE; ASIA; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; EUROPE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGING; BIOPSY; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84885066300     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000354646     Document Type: Review

References (40)

1. Berger J, Hinglais N: Intercapillary deposits of IgA-IgG. J Urol Nephrol 1968; 74: 694-695.
2. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727.
3. D'Amico G: Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237.
4. Valderrabano F, Berthoux FC, Jones EH, Mehls O: Report on management of renal failure in Europe, XXV, end-stage renal disease and dialysis report. The EDTA-ERA registry, European Dialysis and Transplant Association. Nephrol Dial Transplant 1994; 11(suppl 1):S2-S21.
5. Cai GY, Chen XM: Immunoglobulin a nephropathy in China: progress and challenges. Am J Nephrol 2009; 30: 268-273.
6. Radford MG, Donadio JV, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
7. Goto M, Kenji W, Kawamura T, et al: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009; 24: 3068-3074.
8. National Institute on Aging: Why population aging matters-a global perspective. http:// www. wepapers. com/Papers/57713/files/ swf/55001To60000/ 57713. swf.
9. Eurostat: Europe in Figures-Eurostat Yearbook. Luxembourg, Office for Official Publications of the European Communities, 2009.
10. US Census Bureau: International Population Reports. 2009.
11. White Book of Aging from the Government of Japan. http://www8. cao. go. jp/kourei/ whitepaper/w-2011/gaiyou/pdf/1s1s. pdf.
12. Soleymanian T, Najafi I, Salimi BH, Broomand B: Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in Iran. Ren Fail 2011; 33: 572-577.
13. Frimat L, Hestin D, Aymard B, et al: IgA nephropathy in patients over 50 years of age: a multicentre, prospective study. Nephrol Dial Transplant 1996; 11: 1043-1047.
14. Harris RP, Helfand M, Woolf SH, et al: Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20: 21-35.
15. Jones-Burton C, Seliger SL, Scherer RW, et al: Cigarette smoking and incident chronic kidney disease: a systematic review. Am J Nephrol 2007; 27: 342-351.
16. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
18. Kuhara T, Okada K: Clinicopathological study of IgA nephropathy: the influence of age on renal histological changes and prognosis. Jpn J Nephrol 1995; 37: 391-396.
19. Hao CL, Chen JJ, Zhang HX, et al: Clinical presentation and pathologic feature of 524 patients with IgA nephropathy. Clin J Nephrol 2000; 16: 324-327.
20. Takeda A, Takimoto H, Niimura F, et al: Agerelated differences in IgA nephropathy. Jpn J Nephrol 1999; 41: 731-736.
21. Yang YR, Lv JC, Jiang L, et al: Clinicopathologic characteristics and outcomes of IgA nephropathy in elder patients. Beijing Da Xue Xue Bao 2008; 40: 401-404.
22. Ferro G, Dattolo P, Nigrelli S, et al: Clinical pathological correlates of renal biopsy in elderly patients. Clin Nephrol 2006; 65: 243-247.
23. Rivera F, Lopez-Gomez JM, Perez-Garcia R, Spanish Registry of Glomerulonephritis: Clinicopathologic correlations of renal pathology in Spain. Kidney Int 2004; 66: 898-904.
24. Yokoyama H, Sugiyama H, Sato H, et al: Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2012; 16: 903-920.
25. Wakai K, Kawamura T, Endoh M, et al: A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006; 21: 2800-2808.
26. Sugiyama H, Yokoyama H, Sato H, et al: Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15: 493-503.
27. Schena FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-215.
28. Manno C, Giovanni F, Strippoli M, et al: A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007; 49: 763-775.
29. Barbour SJ, Reich HN: Risk stratification of patients with IgA nephropathy. Am J Kidney Dis 2012; 59: 865-873.
30. Gharavi AG, Kiryluk K, Choi M, et al: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011; 43: 321-327.
31. Kiryluk K, Li Y, Sanna-Cherchi S, et al: Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 2012; 8:e1002765.
32. Long DA, Mu W, Price KL, Johnson RJ: Blood vessels and the aging kidney. Nephron Exp Nephrol 2005; 101:e95-e499.
33. Zhao H, Gong J, Wang Y, Zhang Z, Qin P: Renal hemodynamic changes with aging: a preliminary study using CT perfusion in the healthy elderly. Clin Imaging 2010; 34: 247-250.
34. Hollenberg NK, Adams DF, Solomon HS, et al: Senescence and the renal vasculature in normal man. Circ Res 1974; 34: 309-316.
35. Kaplan C, Pasternack B, Shah H, Gallo G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80: 227-234.
36. Neugarten J, Gallo G, Silbiger S, Kasiske B: Glomerulosclerosis is aging humans is not influenced by gender. Am J Kidney Dis 1999; 34: 884-888.
37. Myllymaki JM, Honkanen TT, Syrjanen JT, et al: Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int 2007; 71: 343-348.
38. Mei C, Zheng F: Chronic inflammation potentiates kidney aging. Semin Nephrol 2009; 29: 555-568.
39. Fried L, Solomon C, Shlipak M, et al: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004; 15: 3184-3191.
40. Kaartinen K, Syrjanen J, Porsti I, et al: Inflammatory markers and the progression of IgA glomerulonephritis. Nephrol Dial Transplant 2008; 23: 1285-1290.